Your browser doesn't support javascript.
loading
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Swain, S M; Ewer, M S; Viale, G; Delaloge, S; Ferrero, J-M; Verrill, M; Colomer, R; Vieira, C; Werner, T L; Douthwaite, H; Bradley, D; Waldron-Lynch, M; Kiermaier, A; Eng-Wong, J; Dang, C.
Afiliação
  • Swain SM; Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, USA. Electronic address: sandra.swain@georgetown.edu.
  • Ewer MS; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Viale G; Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy.
  • Delaloge S; Department of Medical Oncology, Institut Gustave Roussy, Villejuif.
  • Ferrero JM; Clinical Research Department, Centre Antoine Lacassagne, Nice, France.
  • Verrill M; Medical Oncology Department, Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
  • Colomer R; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain.
  • Vieira C; Medical Oncology, Instituto Português de Oncologia Francisco Gentil (IPOFG) Porto, Porto, Portugal.
  • Werner TL; Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
  • Douthwaite H; Biostatistics, Product Development, Roche Products Ltd, Welwyn Garden City, UK.
  • Bradley D; Clinical Science, Global Product Development, Roche Products Ltd, Welwyn Garden City, UK.
  • Waldron-Lynch M; Clinical Science, Global Product Development, Roche Products Ltd, Welwyn Garden City, UK.
  • Kiermaier A; Oncology Biomarker Development (OBD), F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Eng-Wong J; Product Development - Oncology, Genentech, Inc., South San Francisco.
  • Dang C; Department of Medicine, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA.
Ann Oncol ; 29(3): 646-653, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29253081
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante / Cardiotoxicidade Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante / Cardiotoxicidade Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article